Not yet recruitingPhase 3NCT06476639
A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer
Studying Vulvar carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Queensland Centre for Gynaecological Cancer
- Principal Investigator
- Andreas Obermair, MDDirector, Queensland Centre for Gynaecological Cancer Research
- Intervention
- High-resolution bilateral groin ultrasound monitoring(diagnostic_test)
- Enrollment
- 640 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2026 – 2035
Study locations (9)
- John Hunter Hospital, Newcastle, New South Wales, Australia
- The Royal Darwin Hospital, Darwin, Northern Territory, Australia
- The Wesley Hospital, Auchenflower, Queensland, Australia
- St Andrew's War Memorial Hospital, Brisbane, Queensland, Australia
- Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
- Buderim Private Hospital, Buderim, Queensland, Australia
- Royal Adelaide Hospital, Adelaide, South Australia, Australia
- Mercy Hospital for Women, Heidelberg, Victoria, Australia
- Royal Women's Hospital, Parkville, Victoria, Australia
Collaborators
Royal Brisbane and Women's Hospital · The University of Queensland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06476639 on ClinicalTrials.govOther trials for Vulvar carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)Imperial College London
- RECRUITINGNCT07380698The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological CancerCukurova University
- ENROLLING BY INVITATIONNANCT07023601International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.Hospital Universitario La Paz
- RECRUITINGPHASE2NCT05903833Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or RadiotherapyAGO Research GmbH
- RECRUITINGNANCT05576831STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide ExcisionBritish Columbia Cancer Agency
- RECRUITINGNANCT06495554Danish Vulva Cancer Recurrence StudyUniversity of Aarhus
- RECRUITINGNANCT06264167NODE (groiN ultrasOunD cancEr)Queensland Centre for Gynaecological Cancer
- ACTIVE NOT RECRUITINGNANCT06694116Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar CancerIstanbul University